{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:09:50Z","timestamp":1720570190237},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T00:00:00Z","timestamp":1535673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00101-018-0483-9","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T13:00:21Z","timestamp":1535720421000},"page":"637-646","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Wenn A nicht mehr A ist: Schwierigkeiten und Fallstricke bei der Blutgruppenbestimmung","When A is not A anymore: problems and pitfalls with blood group typing"],"prefix":"10.1007","volume":"67","author":[{"given":"P.","family":"M\u00f6hnle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Humpe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,31]]},"reference":[{"key":"483_CR1","volume-title":"Immunh\u00e4matologie und Immungenetik, Empfehlung zum Vorgehen bei serologischen St\u00f6rungen durch den therapeutischen monoklonalen Antik\u00f6rper Daratumumab (Darzalex\u00ae)","author":"Deutsche Gesellschaft f\u00fcr Transfusionsmedizin und Immunh\u00e4matologie (DGTI), Sektion V","year":"2016","unstructured":"Deutsche Gesellschaft f\u00fcr Transfusionsmedizin und Immunh\u00e4matologie (DGTI), Sektion V (2016) Immunh\u00e4matologie und Immungenetik, Empfehlung zum Vorgehen bei serologischen St\u00f6rungen durch den therapeutischen monoklonalen Antik\u00f6rper Daratumumab (Darzalex\u00ae)"},{"key":"483_CR2","unstructured":"DGTI Arbeitsgruppe Seltene Blutgruppen, German Rare Donor Program, http:\/\/www.seltene-blutgruppen.de\/RARE\/index.html . Zugegriffen: 2. Juli 2018"},{"key":"483_CR3","unstructured":"H\u00e4movigilanz-Bericht des Paul-Ehrlich-Instituts 2015, Auswertung des Meldungen von schwerwiegenden Reaktionen und Zwischenf\u00e4llen nach \u00a7\u00a063 i AMG"},{"key":"483_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1537-2995.2007.01505.x","volume":"48","author":"N Ahrens","year":"2008","unstructured":"Ahrens N, Pruss A, Mayer B, Genth R, Kiesewetter H, Salama A (2008) Association between alloantibody specificity and autoantibodies to red blood cells. Transfusion 48:20\u201324","journal-title":"Transfusion"},{"key":"483_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMoa0707255","volume":"358","author":"SI Alexander","year":"2008","unstructured":"Alexander SI, Smith N, Hu M, Verran D, Shun A, Dorney S, Smith A, Webster B, Shaw PJ, Lammi A, Stormon MO (2008) Chimerism and tolerance in a\u00a0recipient of a\u00a0deceased-donor liver transplant. N\u00a0Engl J Med 358:369\u2013374","journal-title":"N Engl J Med"},{"key":"483_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0037-1963(00)90043-X","volume":"37","author":"ML Beck","year":"2000","unstructured":"Beck ML (2000) Red blood cell polyagglutination: clinical aspects. Semin Hematol 37:186\u2013196","journal-title":"Semin Hematol"},{"key":"483_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2141.1976.tb03541.x","volume":"33","author":"GW Bird","year":"1976","unstructured":"Bird GW, Wingham J, Chester GH, Kidd P, Payne RW (1976) Erythrocyte membrane modification in malignant disease of myeloid and lymphoreticular tissues. II. Erythrocyte \u201cmosaicism\u201d in acute erythroleukaemia. Br J Haematol 33:295\u2013299","journal-title":"Br J Haematol"},{"key":"483_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2141.1976.tb03540.x","volume":"33","author":"GW Bird","year":"1976","unstructured":"Bird GW, Wingham J, Pippard MJ, Hoult JG, Melikian V (1976) Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia. Br J Haematol 33:289\u2013294","journal-title":"Br J Haematol"},{"key":"483_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/tme.12380","volume":"26","author":"PH Bolton-Maggs","year":"2016","unstructured":"Bolton-Maggs PH (2016) SHOT conference report 2016: serious hazards of transfusion\u2014human factors continue to cause most transfusion-related incidents. Transfus Med 26:401\u2013405","journal-title":"Transfus Med"},{"key":"483_CR10","volume-title":"Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Richtlinie H\u00e4motherapie), Gesamtnovelle 2017","author":"Bundes\u00e4rztekammer","year":"2017","unstructured":"Bundes\u00e4rztekammer (2017) Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Richtlinie H\u00e4motherapie), Gesamtnovelle 2017"},{"key":"483_CR11","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/trf.13069","volume":"55","author":"CI Chapuy","year":"2015","unstructured":"Chapuy CI, Nicholson RT, Aguad MD, Chapuy B, Laubach JP, Richardson PG, Doshi P, Kaufman RM (2015) Resolving the daratumumab interference with blood compatibility testing. Transfusion 55:1545\u20131554","journal-title":"Transfusion"},{"key":"483_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/labmed\/lmw055","volume":"48","author":"MF Dizon","year":"2017","unstructured":"Dizon MF (2017) The challenges of daratumumab in transfusion medicine. Lab Med 48:6\u20139","journal-title":"Lab Med"},{"key":"483_CR13","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2352-3026(16)30019-9","volume":"3","author":"D Evers","year":"2016","unstructured":"Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KM, van de Kerkhof D, Visser O, Pequeriaux NC, Hudig F, Schonewille H, Zwaginga JJ, van der Bom JG (2016) Red-blood-cell alloimmunisation in relation to antigens\u2019 exposure and their immunogenicity: a\u00a0cohort study. Lancet Haematol 3:e284\u2013e292","journal-title":"Lancet Haematol"},{"key":"483_CR14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1046\/j.1537-2995.1990.30690333485.x","volume":"30","author":"CR Fluit","year":"1990","unstructured":"Fluit CR, Kunst VA, Drenthe-Schonk AM (1990) Incidence of red cell antibodies after multiple blood transfusion. Transfusion 30:532\u2013535","journal-title":"Transfusion"},{"key":"483_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1046\/j.1537-2995.1996.36496226152.x","volume":"36","author":"G Garratty","year":"1996","unstructured":"Garratty G, Arndt P, Co A, Rodberg K, Furmanski M (1996) Fatal hemolytic transfusion reaction resulting from ABO mistyping of a\u00a0patient with acquired B antigen detectable only by some monoclonal anti-B reagents. Transfusion 36:351\u2013357","journal-title":"Transfusion"},{"key":"483_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/asheducation-2006.1.19","volume":"2006","author":"MA Gertz","year":"2006","unstructured":"Gertz MA (2006) Cold hemolytic syndrome. Hematology Am Soc Hematol Educ Program 2006:19\u201323","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"483_CR17","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1365-2141.1995.tb05425.x","volume":"91","author":"NM Heddle","year":"1995","unstructured":"Heddle NM, Soutar RL, O\u2019Hoski PL, Singer J, McBride JA, Ali MA, Kelton JG (1995) A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 91:1000\u20131005","journal-title":"Br J Haematol"},{"key":"483_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000441612","volume":"43","author":"PM Kopko","year":"2016","unstructured":"Kopko PM (2016) Transfusion support for ABO-incompatible progenitor cell transplantation. Transfus Med Hemother 43:13\u201318","journal-title":"Transfus Med Hemother"},{"key":"483_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.21307\/immunohematology-2019-012","volume":"33","author":"GM Meny","year":"2017","unstructured":"Meny GM (2017) Recognizing and resolving ABO discrepancies. Immunohematology 33:76\u201381","journal-title":"Immunohematology"},{"key":"483_CR20","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1537-2995.2011.03465.x","volume":"52","author":"D O\u2019Donghaile","year":"2012","unstructured":"O\u2019Donghaile D, Kelley W, Klein HG, Flegel WA (2012) Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation. Transfusion 52:456\u2013458","journal-title":"Transfusion"},{"key":"483_CR21","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/trf.13150","volume":"55","author":"M Oostendorp","year":"2015","unstructured":"Oostendorp M, Lammerts van Bueren JJ, Doshi P, Khan I, Ahmadi T, Parren PW, van Solinge WW, De Vooght KM (2015) When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy. Transfusion 55:1555\u20131562","journal-title":"Transfusion"},{"key":"483_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000462061","volume":"71","author":"M Redman","year":"1996","unstructured":"Redman M, Regan F, Contreras M (1996) A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 71:216\u2013220","journal-title":"Vox Sang"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s002770050543","volume":"78","author":"LM Repas-Humpe","year":"1999","unstructured":"Repas-Humpe LM, Humpe A, Lynen R, Glock B, Dauber EM, Simson G, Mayr WR, Kohler M, Eber S (1999) A dispermic chimerism in a\u00a02-year-old Caucasian boy. Ann Hematol 78:431\u2013434","journal-title":"Ann Hematol"},{"key":"483_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1046\/j.1442-2026.2003.00442.x","volume":"15","author":"J Saverimuttu","year":"2003","unstructured":"Saverimuttu J, Greenfield T, Rotenko I, Crozier J, Jalaludin B, Harvey M (2003) Implications for urgent transfusion of uncrossmatched blood in the emergency department: The prevalence of clinically significant red cell antibodies within different patient groups. Emerg Med (Fremantle) 15:239\u2013243","journal-title":"Emerg Med (Fremantle)"},{"key":"483_CR25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21307\/immunohematology-2019-056","volume":"32","author":"EA Scharberg","year":"2016","unstructured":"Scharberg EA, Olsen C, Bugert P (2016) The H blood group system. Immunohematology 32:112\u2013118","journal-title":"Immunohematology"},{"key":"483_CR26","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1537-2995.2006.00708.x","volume":"46","author":"H Schonewille","year":"2006","unstructured":"Schonewille H, van de Watering LM, Loomans DS, Brand A (2006) Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 46:250\u2013256","journal-title":"Transfusion"},{"key":"483_CR27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21307\/immunohematology-2019-418","volume":"20","author":"F Yamamoto","year":"2004","unstructured":"Yamamoto F (2004) Review: ABO blood group system\u2014ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematology 20:3\u201322","journal-title":"Immunohematology"},{"key":"483_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tmrv.2005.02.003","volume":"19","author":"MH Yazer","year":"2005","unstructured":"Yazer MH (2005) What a\u00a0difference 2 nucleotides make: a\u00a0short review of ABO genetics. Transfus Med Rev 19:200\u2013209","journal-title":"Transfus Med Rev"},{"key":"483_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/ajh.23218","volume":"87","author":"ND Zantek","year":"2012","unstructured":"Zantek ND, Koepsell SA, Tharp DR Jr., Cohn CS (2012) The direct antiglobulin test: a\u00a0critical step in the evaluation of hemolysis. Am J Hematol 87:707\u2013709","journal-title":"Am J Hematol"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-018-0483-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-018-0483-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T20:25:57Z","timestamp":1720556757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-018-0483-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,31]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1007\/s00101-018-0483-9","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,31]]},"assertion":[{"value":"31 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0M\u00f6hnle, A.\u00a0Humpe und G.\u00a0Wittmann geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}